期刊文献+

不同糖耐量患者血浆同型半胱氨酸与血清C反应蛋白的改变 被引量:3

Plasma homocysteine and serum C-reactive protein levels in patients with different glucose intolerance
原文传递
导出
摘要 目的:探讨不同糖耐量阶段血浆同型半胱氨酸(Hcy)与血清C反应蛋白(CRP)的改变及两者的关系。方法:测定新发糖尿病组(T2DM,30例),糖耐量低减组(IGT,35例),对照组即正常糖耐量组(NGT,40例)血浆Hcy、叶酸、VitB12和血清CRP的水平。Hcy采用免疫荧光偏振法测定,CRP采用酶联免疫法测定,化学发光法测定血浆叶酸、VitB12浓度。结果:NGT、IGT、DM各组中,血清CRP水平逐渐升高(P<0.001),IGT与新发DM组血浆Hcy显著高于NGT组(P<0.01),新发DM组Hcy略高于IGT组,但无统计学差异(P>0.05);叶酸、VitB12水平在NGT、IGT、DM各组中依次减低,且NGT组与IGT、DM组相比,差异有显著性(P<0.05)。相关分析显示Hcy与CRP(r=0.231,P=0.034)、尿Alb/Cr(r=0.327,P=0.001)、FBG(r=0.236,P=0.017)呈显著正相关关系,与叶酸(r=-0.294,P=0.003)、VitB12(r=-0.328,P=0.001)显著负相关。结论:随着糖耐量的恶化,血浆Hcy与血清CRP水平逐渐升高,可能与叶酸、VitB12的缺乏及胰岛素抵抗的加重有关。血浆Hcy与血清CRP可能参与了糖耐量异常患者血管病变的发生。 Objective: To investigate the changes of plasma homocysteine (Hey) and serum C reactive protein (CRP) levels in subjects with different glucose tolerance and their relation. Methods: A total of 105 subjects were recruited in this study. Among these subjects, 40 were healthy controls with normal glucose tolerance ( NGT), 35 had impaired glucose tolerance (IGT), 30 had newly diagnosed type 2 diabetes mellitus (DM). Plasma Hey levels were measured by polarization immunoassay (FPIA) , serum CRP concentrations were determined by enzymatic linked immunosorbbent assay (ELISA) , plasma folic acid and vitamin B12 levels were measured by radioimmunoassay. Results: Plasma Hey concentrations were significantly higher in patients with IGT and DM than in patients with NGT [ median (25% and 75% ), IGT 7.08(6.45 - 8.58) μmol/L, DM 8.58 (6.97 -9.46)μmol/L, NGT 5.64 (5.17 -8.00)μmol/L, P 〈0.05) ]. The serum CRP level [median (25%, 75% ) ] was 0.37 (0.18 - 0.89 ) mg/L in patients with NGT and 1.34 ( 0.53 - 2.79 ) mg/L in patients with IGT, 1.66 ( 1.08 - 2.27 ) mg/L in patients with type 2 DM (P 〈 0.05 ) respectively, while folie acid and vitamin B12 levels decreased gradually with the worsening glucose tolerance ( P 〈 0.05 ). Plasma Hey concentrations were positively correlated with serum CRP and urine Alb/Cr levels ( r = 0.231, P = 0. 034 ; r = 0.327, P = 0. 001, respectively), and negatively correlated with plasma folio acid and vitamin B12 levels ( r = - 0.294, P = 0. 003 ; r = - 0. 328, P = 0.001 ). Conclusion: With the worsening of glucose tolerance, the Hey and CRP levels increase gradually. Deficiency in folic acid and vitamin B12 and insulin resistance might be responsible for the increased Hey and CRP levels in patients with abnormal glucose tolerance. Hey and CRP might partially account for the increased risk of developing vasculopathy in patients with abnormal glucose tolerance.
出处 《军医进修学院学报》 CAS 2009年第3期264-266,共3页 Academic Journal of Pla Postgraduate Medical School
基金 北京市首都医学科研发展基金联合攻关课题(2003-1009)~~
关键词 同型半胱氨酸 C反应蛋白质 糖耐量低减 糖尿病 homoeysteine C-reactive protein impaired glucose tolerance diabetes mellitus
  • 相关文献

参考文献6

  • 1Surdacki A,Stochmal E,Szurkowska M,et al.Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance[J].Metabolism,2007,56 (1):77 -86.
  • 2杨国庆,陆菊明,潘长玉.血浆同型半胱氨酸浓度与2型糖尿病视网膜病变的关系[J].中华内科杂志,2002,41(1):34-38. 被引量:62
  • 3Watanabe N,Taniguchi T,Taketoh H,et al.Elevated remnantlike lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients[J].Diabetes Care,1999,22(1):152-156.
  • 4Spranger J,Kroke A,Mohlig M,et al.Inflammatory cytokines and the rik to develop type 2 diabetes:results of the prospective population based European Prospective Investigation into Cancer and Nutrition Potsdam study[J].Diabetes,2003,52 (3):812-817.
  • 5Pradhan AD,Manson JE,Rifai N,et al.C-reactive proteine,interleukin 6,and risk of developing type 2 diabetes mellitus[J].JAMA,2001,286(3):327-334.
  • 6Romano M,Pomilio M,Vigneri S,et al.Endothelial perturbation in children and adolescents with type 1 diabetes:association with markers of the inflammatory reaction[J].Diabetes Care,2001,24 (9):1674-1678.

二级参考文献10

  • 1Fonseca VA, Mudaliar S, Schmidt B ,et al. Plasma homocysteine concentration are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism, 1998,47:686-689.
  • 2Wollesen F, Brattstrom L, Refsum H, et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int, 1999, 55:1028-1035.
  • 3Vaccaro O, Ingrosso D, Rivellese A, et al. Moderate hyper-homocysteinaemia and retinopathy in insulin-dependent diabetes. Lancet,1997,349:1102-1103.
  • 4Tsai JC, Wang H, Perrella MA, et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest, 1996,97:146-152.
  • 50 Blom HJ, Kleinveld HA, Boers GH, et al. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest, 1995,25:149-154.
  • 6Montalescot G,Ankri A,Chadefaux-Vekemans B,et al. Plasmsa homocysteine and the extent of atherosclerosis in patients with coronary disease. Int J Cardiol, 1997,60:295-300.
  • 7Gilfix BM, Blank DW, Rosenblatt DS. Novel reductant for deter-mination of total plasma homocysteine. Clin Chem, 1997,43:687-688.
  • 8Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arherioscler Thromb Vasc Biol, 1998,18:133-138.
  • 9van den Berg M, Stehouwer CD, Bierdrager E, et al. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arherioscler Thromb Vasc Biol, 1996,16:165-171.
  • 10Drzewoski J, Czupryniak L, Chwatko G, et al. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care, 1999,22:2097-2099.

共引文献61

同被引文献20

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部